Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Genitourinary 2Breast 1

Conditions

Breast Neoplasms 485Triple Negative Breast Neoplasms 28Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms, Male 22Neoplasms 20Inflammatory Breast Neoplasms 20Neoplasm Metastasis 19Prostatic Neoplasms 17HER2-positive Breast Cancer 16Ovarian Neoplasms 13Lung Neoplasms 13Stomach Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Head and Neck Neoplasms 9Melanoma 8Esthesioneuroblastoma, Olfactory 8Carcinoma, Renal Cell 8Urinary Bladder Neoplasms 7Small Cell Lung Carcinoma 7Salivary Gland Neoplasms 7Pancreatic Neoplasms 7Esophageal Neoplasms 7Neutropenia 6Breast Diseases 6Sarcoma 5Carcinoma, Ovarian Epithelial 5Uterine Cervical Neoplasms 4Primary Breast Cancer 4Pathologic Complete Response 4Endometrial Neoplasms 4

Interventions

pembrolizumab 9Nivolumab 4budigalimab 2belinostat 2Pemetrexed 2Ipilimumab 2Cyclophosphamide 2Cisplatin 2Carboplatin 2venetoclax 1tocilizumab 1tislelizumab 1talazoparib 1spartalizumab 1rovalpituzumab tesirine 1ribociclib 1rebastinib 1obinutuzumab 1naptumomab estafenatox 1fludarabine 1epacadostat 1enzalutamide 1durvalumab 1cabozantinib 1abemaciclib 1Valacyclovir 1Sorafenib 1Sirolimus 1Quality of Life 1Plicamycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Docetaxel × Breast × Clear all
NCT02071862 2022-07-20

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Calithera Biosciences, Inc

Phase 1 Completed
210 enrolled
BreastGenitourinaryOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡